| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €23.8392 | +4.40% | €1.50B | €584.98K | |
SGRY Surgery Partners, Inc. Common Stock | €11.6289 | -1.96% | €1.50B | €1.21M | |
GAB The Gabelli Equity Trust Inc. | €4.8283 | -0.26% | €1.50B | €664.08K | |
HURN Huron Consulting Group Inc. | €90.2360 | -1.74% | €1.49B | €170.69K | |
ENVX Enovix Corporation Common Stock | €7.0807 | -4.64% | €1.49B | €6.28M | |
PAYO Payoneer Global Inc. Common Stock | €4.3802 | -4.95% | €1.49B | €3.99M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12.8435 | -0.27% | €1.49B | €139.49K | |
STGW Stagwell Inc. Class A Common Stock | €5.6766 | -8.47% | €1.49B | €1.48M | |
CASH Pathward Financial, Inc. Common Stock | €66.9136 | -4.58% | €1.49B | €319.85K | |
SNDX Syndax Pharmaceuticals, Inc. | €15.8024 | -0.25% | €1.49B | €1.07M | |
STRA Strategic Education, Inc. Common Stock | €68.0851 | -0.15% | €1.49B | €152.01K | |
CAPR Capricor Therapeutics Inc | €23.8349 | +1.21% | €1.49B | €572.66K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15.3545 | -3.39% | €1.49B | €19.44K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7.0549 | -1.68% | €1.49B | €6.49M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €21.5350 | +2.97% | €1.49B | €225.25K | |
